INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$21.51M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 178 insiders$2.77M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

73,606 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
15
VC
van Es CharlesChief Sales Officer
COCOVita Coco Company, Inc.
Tax withholding
F$285K
5,300 sh
Nov 27, 2025Dec 1, 2025
Page 1714 of 1841
← PrevNext →
traded Nov 27, 2025
+4d
SEC Form 4

Evidence

15
JN
Jain NalinDirector
ASTEASTEC INDUSTRIES INC
Grant or award
A—
10 sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

15
CH
Cook Tracey HDirector
ASTEASTEC INDUSTRIES INC
Grant or award
A—
10 sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

15
AA
Azoy AlexanderChief Accounting Officer
RCUSArcus Biosciences, Inc.
Open-market sale · 10b5-1 plan
SELL$49K
1,900 sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

15
BV
Bali VinitaDirector
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Grant or award
A—
12 sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

15
FE
Freeland James E.VP, Chief Information Officer
DGIIDIGI INTERNATIONAL INC
Tax withholding
F$19K
459 sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

15
SJ
Scofield JeffreyDirector
CVEOCiveo Corp
Grant or award
A—
5,618 sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

15
NP
Norris Michael PaulGROUP PRESIDENT
ASTEASTEC INDUSTRIES INC
Grant or award
A—
28 sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

15
BG
Bell Hans G.President of Subsidiary
UGIUGI CORP /PA/
Option exercise
M—
11.3K sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

15
WM
Winford James Murphy JrDirector
ASTEASTEC INDUSTRIES INC
Grant or award
A—
10 sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

14
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Tax withholding
F$499K
1,121 sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

13
LH
Lee John HoonDirector
LDIloanDepot, Inc.
Option exercise
M—
24.6K sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

13
PH
Patenaude Pamela H.Director
LDIloanDepot, Inc.
Option exercise
M—
24.6K sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

13
AA
Azoy AlexanderChief Accounting Officer
RCUSArcus Biosciences, Inc.
Option exercise · 10b5-1 plan
M—
1,900 sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

13
MW
McClintock WilliamDirector
IDAIT Stamp Inc
Grant or award
A—
52 sh
Nov 30, 2025Dec 1, 2025
traded Nov 30, 2025
+1dSEC Form 4

Evidence

13
SJ
Seybold David J.CEO, TTEC DIGITAL
TTECTTEC Holdings, Inc.
Tax withholding
F$13K
3,946 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

13
PE
Potts Charles EdwardDirector
IDAIT Stamp Inc
Grant or award
A—
726 sh
Nov 30, 2025Dec 1, 2025
traded Nov 30, 2025
+1dSEC Form 4

Evidence

13
FL
Fulcher LinneChief Operating Officer
VVVVALVOLINE INC
Option exercise
M—
794 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

13
SD
Sturgeon DioneChief Accounting Officer
VVVVALVOLINE INC
Option exercise
M—
398 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

13
OS
Ozonian StevenDirector
LDIloanDepot, Inc.
Option exercise
M—
24.6K sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

12
LJ
Loch James J.SR VP, CFO AND TREASURER
DGIIDIGI INTERNATIONAL INC
Tax withholding
F$80K
1,902 sh
Nov 30, 2025Dec 1, 2025
traded Nov 30, 2025
+1dSEC Form 4

Evidence

12
TE
Tessari EbenCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$8,578
200 sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

12
GC
Gantt Greg CDirector
ODFLOLD DOMINION FREIGHT LINE, INC.
Tax withholding
F$86K
635 sh
Dec 1, 2025Dec 1, 2025
traded Dec 1, 2025
+0dSEC Form 4

Evidence

12
HA
Harrington Lauren AEVP and General Counsel
ARMKAramark
Tax withholding
F$53K
1,433 sh
Nov 27, 2025Dec 1, 2025
traded Nov 27, 2025
+4dSEC Form 4

Evidence

12
RG
Rosenbaum Michael GeorgeDirector, Chief Executive Officer
GWREGuidewire Software, Inc.
Open-market sale · 10b5-1 plan
SELL$299K
1,400 sh
Dec 1, 2025Dec 1, 2025
traded Dec 1, 2025
+0dSEC Form 4

Evidence

12
BA
Bruno Marc ACOO, U.S. Food & Facilities
ARMKAramark
Tax withholding
F$52K
1,400 sh
Nov 27, 2025Dec 1, 2025
traded Nov 27, 2025
+4dSEC Form 4

Evidence

12
PJ
Prior JaneChief Marketing Officer
COCOVita Coco Company, Inc.
Tax withholding
F$62K
1,152 sh
Nov 27, 2025Dec 1, 2025
traded Nov 27, 2025
+4dSEC Form 4

Evidence

12
DD
DeSantis Dean10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
187.5K sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

12
MH
Milmoe William H.10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
187.5K sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

12
MH
Milmoe William H.10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
112.5K sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

12
HR
Harmer RyanPrincipal Accounting Officer
CRCTCricut, Inc.
Gift
G—
7,260 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

12
DD
DeSantis Dean10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
112.5K sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

12
DD
DeSantis Deborah10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
187.5K sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

11
SG
Schneider Terrence G.VP, SUPPLY CHAIN
DGIIDIGI INTERNATIONAL INC
Tax withholding
F$33K
772 sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

11
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Option exercise
M$200K
2,352 sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

11
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Option exercise
M$100K
839 sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

11
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Option exercise
M$100K
847 sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

11
AA
Asmerom AmineChief Accounting Officer
CHYMChime Financial, Inc.
Open-market sale · 10b5-1 plan
SELL$703K
34.6K sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC Form 4

Evidence

11
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Option exercise
M$100K
659 sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence

10
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$98K
20.4K sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC Form 4

Evidence